Literature DB >> 9833201

A survey of mental health consumers' and family members' involvement in advocacy.

C J Evans1, A C McGaha.   

Abstract

As the service delivery system is redesigned, the involvement of consumers and family members in mental health policy-making is essential. Advocacy is a way for them to have an impact on policy or decision-making. To determine the extent of their participation in advocacy efforts, consumers and family members were surveyed by other consumers and family members about their involvement in advocacy and mental healthcare reform. Although more family than consumers reported receiving mental healthcare reform information, both groups had difficulty understanding this information. Consumers were more likely to have received information from a mental health professional while family were more likely to have received information from an advocacy group. Lack of economic resources and communication problems were the most often cited barriers to advocacy for consumers. Strategies are suggested for how to increase involvement of consumers and family in advocacy efforts. The limitations of conducting a state-wide study with consumers and family as data collectors is discussed.

Mesh:

Year:  1998        PMID: 9833201     DOI: 10.1023/a:1018715102256

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  3 in total

1.  The potential of consumer participation: sources of understanding.

Authors:  J Lord
Journal:  Can Ment Health       Date:  1989-06

2.  An advocacy perspective on the AMBHA/NASMHPD White Paper.

Authors:  M M Faenza; L S Rubenstein
Journal:  Behav Healthc Tomorrow       Date:  1996-04

3.  Benefits and challenges of using consumer staff in supported housing services.

Authors:  S W Besio; J Mahler
Journal:  Hosp Community Psychiatry       Date:  1993-05
  3 in total
  1 in total

Review 1.  Service user involvement in mental health care: an evolutionary concept analysis.

Authors:  Samantha L Millar; Mary Chambers; Melanie Giles
Journal:  Health Expect       Date:  2015-02-13       Impact factor: 3.377

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.